| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Editas Medicine, Inc. (EDIT) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. EDIT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 269.1K | $723.8K | - | |
| VP | 68.8K | $185.0K | - | |
| CFO | 15.9K | $42.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2018 | Bosley Katrine | President And CEO | Sell | 8,333 | $36.18 | $301,451.00 | -0.2% | |
| Jan 30, 2018 | Bosley Katrine | President And CEO | Sell | 20,000 | $38.79 | $775,860.00 | -0.7% | |
| Jan 23, 2018 | Bosley Katrine | President And CEO | Sell | 3,338 | $35.28 | $117,764.64 | -0.2% | |
| Jan 3, 2018 | Bosley Katrine | President And CEO | Sell | 14,995 | $34.15 | $512,053.31 | -0.2% | |
| Dec 19, 2017 | Hack Andrew A. F.62 | Chief Financial Officer | Sale+OE | 14,649 | $24.68 | $361,465.45 | -100% | |
| Dec 1, 2017 | Bosley Katrine | President And CEO | Sell | 8,333 | $29.58 | $246,522.46 | -0.3% | |
| Nov 20, 2017 | Hack Andrew A. F.62 | Chief Financial Officer | Sale+OE | 10,000 | $25.08 | $250,805.00 | -100% | |
| Nov 1, 2017 | Bosley Katrine | President And CEO | Sell | 8,333 | $23.64 | $196,966.09 | -0.2% | |
| Oct 2, 2017 | Bosley Katrine | President And CEO | Sell | 8,333 | $24.78 | $206,525.29 | -0.3% | |
| Sep 5, 2017 | Bosley Katrine | President And CEO | Sell | 16,666 | $20.33 | $338,831.38 | -0.4% |